Reviewing Joint (JYNT) & Health Discovery (HDVY)

Joint (NASDAQ:JYNT) and Health Discovery (OTCMKTS:HDVY) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

Analyst Ratings

This is a summary of recent ratings for Joint and Health Discovery, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Joint 0 0 3 0 3.00
Health Discovery 0 0 0 0 N/A

Joint currently has a consensus target price of $11.00, suggesting a potential upside of 39.24%. Given Joint’s higher possible upside, equities research analysts clearly believe Joint is more favorable than Health Discovery.

Profitability

This table compares Joint and Health Discovery’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Joint -3.72% -34.99% -6.02%
Health Discovery N/A N/A N/A

Volatility and Risk

Joint has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500. Comparatively, Health Discovery has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500.

Institutional and Insider Ownership

51.9% of Joint shares are held by institutional investors. Comparatively, 0.4% of Health Discovery shares are held by institutional investors. 3.2% of Joint shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Joint and Health Discovery’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Joint $25.16 million 4.31 -$3.27 million ($0.25) -31.60
Health Discovery $40,000.00 36.68 -$580,000.00 N/A N/A

Health Discovery has lower revenue, but higher earnings than Joint.

Summary

Health Discovery beats Joint on 6 of the 11 factors compared between the two stocks.

Joint Company Profile

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics in the United States. It operates through direct ownership, management arrangements, franchising, and the sale of regional developer rights. As of August 9, 2018, the company operated approximately 400 clinics. The company was founded in 2010 and is headquartered in Scottsdale, Arizona.

Health Discovery Company Profile

Health Discovery Corporation operates as a pattern recognition company that uses mathematical techniques to analyze data to uncover patterns primarily in the field of molecular diagnostics in the United States. The company's intellectual property include Support Vector Machines (SVM), which are mathematical algorithms that allow computers to sift through datasets to identify patterns; recursive feature elimination SVM that identifies and rank orders the data points that contribute the desired results; FGM, which enhances the mapping of genetic pathways involved in the diagnosis and prevention of certain diseases; and biomarkers, which are biological indicators or genetic expression signatures of certain disease states. It also develops a blood test for prostate cancer; and diagnostic test to interpret flow cell cytometry data for myelodysplastic syndrome, as well as provides an image analysis tool for cytogenetic analysis. The company holds a license agreement with NeoGenomics Laboratories, Inc. to develop and sell products in the laboratory testing, molecular diagnostics, clinical pathology, anatomic pathology, and digital image analysis fields. Health Discovery Corporation was founded in 2001 and is based in Atlanta, Georgia.

Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply